La Jolla Price to Earnings To Growth

LJPC -- USA Stock  

Quarterly Earning Report: October 23, 2019  

La Jolla price-to-earnings-to-growth fundamental analysis lookup allows you to check this and other indicators for La Jolla Pharmaceutical Company or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

La Jolla Price to Earnings To Growth Analysis

PEG Ratio indicates potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate.Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates future growth of a firm. The low PEG ratio usually implies that equity instrument is undervalued; where as PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
PEG Ratio 
PE Ratio 
EPS Growth 
More About Price to Earnings To Growth | All Equity Analysis
La Jolla Price to Earnings To Growth  =
La Jolla ValuationFundamentalsBuy or Sell

La Jolla Distress Driver Correlations

Price to Earnings To Growth Pattern

A component of [Equity] representing the cumulative amount of the entities undistributed earnings or deficit. May only be reported annually by certain companies; rather than quarterly.
 Accumulated Retained Earnings Deficit 

About Price to Earnings To Growth

Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Compare to competition
Consolidated Income
Based on latest financial disclosure the price to earnings to growth indicator of La Jolla Pharmaceutical Company is roughly -0.14 times. This is 119.72% lower than that of the Healthcare sector, and 104.46% lower than that of Biotechnology industry, The Price to Earnings To Growth for all stocks is 102.86% higher than the company.

La Jolla Price to Earnings To Growth Peer Comparison

  Price to Earnings To Growth 
      La Jolla Comparables 
La Jolla is currently under evaluation in price to earnings to growth category among related companies.

La Jolla current financial ratios